Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome


Phase 2/3 Results N/A

Summary of Purpose

The purpose of this research study is to gain a preliminary understanding of the safety of sirolimus in Sturge-Weber syndrome (SWS) and determine best outcomes to be used to assess the utility of sirolimus for the treatment of cognitive impairments related to Sturge-Weber syndrome.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 September 2017.

1 Jan 2017 2 Feb 2017 1 Jan 2018 1 Jan 2018 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available